Medgend Icon

Ledgend of Medicine







discontinued


Dial

What is suicide?

Suicide is the taking of one's own life. It is a death that happens when someone harms themselves because they want to end their life. A suicide attempt is when someone harms themselves to try to end their life, but they do not die.

Suicide is a major public health problem and a leading cause of death in the United States. Both suicide and suicide attempts can have lasting harmful effects:

  • People who survive a suicide attempt may have serious injuries that can affect their long-term health. They may also have depression or other mental health concerns.
  • When people die by suicide, it affects their family, friends, and community. They may feel grief, shock, anger, and guilt. Some may develop post-traumatic stress disorder (PTSD), depression, or anxiety. They may also be at risk for suicidal thoughts.
Who is at risk for suicide?

Suicide does not discriminate. It can touch anyone, anywhere, at any time. But there are certain factors that can contribute to the risk of suicide, including:

  • Having attempted suicide before
  • Depression and other mental health disorders
  • Alcohol or drug use disorder
  • Family history of a mental health disorder
  • Family history of an alcohol or drug use disorder
  • Family history of suicide
  • Family violence, including intimate partner violence, child abuse, or sexual abuse
  • Having guns in the home
  • Being in or having recently gotten out of prison or jail
  • Being exposed to others' suicidal behavior, such as a family member, peer, or celebrity
  • Medical illness, including chronic pain
  • Stressful life event, such as a job loss, financial problems, loss of a loved one, a breakup of a relationship, etc.
  • Being between the ages of 15 and 24 years or over age 60
What are the warning signs for suicide?

The warning signs for suicide include:

  • Talking about wanting to die or wanting to kill oneself
  • Making a plan or looking for a way to kill oneself, such as searching online
  • Buying a gun or stockpiling pills
  • Feeling empty, hopeless, trapped, or like there's no reason to live
  • Being in unbearable pain
  • Talking about being a burden to others
  • Using more alcohol or drugs
  • Acting anxious or agitated; behaving recklessly
  • Sleeping too little or too much
  • Withdrawing from family or friends or feeling isolated
  • Showing rage or talking about seeking revenge
  • Displaying extreme mood swings
  • Saying good-bye to loved ones, putting affairs in order

Some people may tell others about their suicidal thoughts. But others may try to hide them. This can make some of the signs harder to spot.

What should I do if I need help or know someone who does?

If you or someone you know has the warning signs for suicide, get help right away, especially if there is a change in behavior. If it is an emergency, dial 911. Otherwise there are five steps that you can take:

  • Ask the person if they're thinking about killing themselves.
  • Keep them safe. Find out whether they have a plan for suicide and keep them away from things that they can use to kill themselves.
  • Be there with them. Listen carefully and find out what they are thinking and feeling.
  • Help them connect to resources that can help them, such as through:
    • Calling or texting the 988 Suicide & Crisis Lifeline at 988.
    • Chatting through Lifeline Chat.
    • For veterans, reaching the Veterans Crisis Line by:
      • Calling 988 and then pressing 1.
      • Texting to 838255.
      • Chatting with them.
  • Stay connected. Staying in touch after a crisis can make a difference.

NIH: National Institute of Mental Health

Dial FDA Approved Drugs

AFREZZA [Insulin Recombinant Human]
RX
-
12 units/inh (inhalation powder)
4 units/inh (inhalation powder)
8 units/inh (inhalation powder)
MannkindApr 17, 2015
  • Administration of a composition comprising insulin complexed with a diketopiperazine..
  • Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
  • Administration of fdkp microparticles comprising insulin..
  • Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
  • Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
  • Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
  • Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
  • Pulmonary administration of a composition comprising insulin bound to a complexing agent..
  • Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
  • Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
  • Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
  • Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
  • Use of an inhaler to administer dry powder medicament.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ALTACE [RamiprilC23H32N2O5]
RX
-
1.25mg (oral capsule)
10mg (oral capsule)
2.5mg (oral capsule)
King PharmsJan 28, 1991
  • Method of reducing risk of myocardial infarction, stroke and death.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BRILINTA [TicagrelorC23H28F2N6O4S]
RX
-
60mg (oral tablet)
90mg (oral tablet)
Astrazeneca PharmsSep 3, 2015
  • Method of inhibiting platelet aggregation.
  • Reduction of the rate of cardiovascular death, myocardial infarction, and stroke in patients with a history of myocardial infarction.
  • Reduction of the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction.
  • Reduction of the rate of thrombotic events in patients with acute coronary syndrome.
  • Treatment of an arterial thrombotic complication in a patient with coronary artery, cerebrovascular or peripheral vascular disease.
  • Treatment of arterial thrombotic complications selected from the group consisting of unstable angina, thrombotic or embolic stroke, transient ischaemic attacks, peripheral vascular disease and myocardial infarction.
  • Treatment of myocardial infarction and stroke in patients with acute coronary syndrome or a history of myocardial infarction.
  • Treatment of myocardial infarction in patients with acute coronary syndrome or a history of myocardial infarction.
  • Treatment of myocardial infarction.
  • Treatment of post-myocardial infarction.
  • Treatment of stable and unstable angina.
  • Treatment of stroke in patients with acute coronary syndrome or a history of myocardial infarction.
  • Treatment of stroke.
  • Treatment of thrombotic stroke.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CARNITOR [LevocarnitineC7H15NO3]
RX
-
1gm/10ml (oral solution)
200mg/ml (injection injectable)
330mg (oral tablet)
Leadiant Biosci IncApr 10, 1986
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 1.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Fresenius MedclNov 30, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 1.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Fresenius MedclNov 30, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.4mg/100ml : 1.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Fresenius MedclAug 19, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 2.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Fresenius MedclNov 30, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 2.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Fresenius MedclNov 30, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.4mg/100ml : 2.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Fresenius MedclAug 19, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 4.25gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Fresenius MedclNov 30, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 4.25gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Fresenius MedclNov 30, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.4mg/100ml : 4.25gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Fresenius MedclAug 19, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 1.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 2.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 4.25gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.3mg/100ml : 1.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareDec 4, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.3mg/100ml : 2.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareDec 4, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.3mg/100ml : 3.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareDec 4, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.3mg/100ml : 4.25gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareDec 4, 1992
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 1.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareJul 9, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 2.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareJul 9, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 3.5gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareNov 18, 1985
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 4.25gm/100ml : 15.2mg/100ml : 567mg/100ml : 392mg/100ml (intraperitoneal solution)
Baxter HlthcareJul 9, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
18.3mg/100ml : 1.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
25.7mg/100ml : 1.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 2.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 3.5gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareNov 18, 1985
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER [Calcium ChlorideCa2Cl2H2O : Dextrose : Magnesium Chloride2ClMg6H2O : Sodium ChlorideClNa : Sodium LactateC3H5O3Na]
RX
-
25.7mg/100ml : 4.25gm/100ml : 5.08mg/100ml : 538mg/100ml : 448mg/100ml (intraperitoneal solution)
Baxter HlthcareApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIASTAT [DiazepamC16H13ClN2O]
RX
-
2.5mg/0.5ml (5mg/ml) (rectal gel)
Valeant Pharms NorthJul 29, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIASTAT ACUDIAL [DiazepamC16H13ClN2O]
RX
-
10mg/2ml (5mg/ml) (rectal gel)
20mg/4ml (5mg/ml) (rectal gel)
Valeant Pharms NorthSep 15, 2005
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIAZEPAM [DiazepamC16H13ClN2O]
RX
-
10mg (oral tablet)
10mg/2ml (5mg/ml) (injection injectable)
2mg (oral tablet)
50mg/10ml (5mg/ml) (injection injectable)
5mg/5ml (oral solution)
BarrNov 1, 1985
Ivax Sub Teva PharmsDec 10, 1986
Mayne PharmaFeb 3, 1987
MylanSep 4, 1985
Vintage PharmsMar 31, 2006
HospiraDec 20, 1988
Dava Pharms IncSep 26, 1985
Lannett Holdings IncJun 24, 2016
West-ward Pharms IntApr 3, 1987
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIAZEPAM INTENSOL [DiazepamC16H13ClN2O]
RX
-
5mg/ml (oral concentrate)
West-ward Pharms IntApr 3, 1987
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIOVAN [ValsartanC24H29N5O3]
RX
-
160mg (oral tablet)
320mg (oral tablet)
40mg (oral tablet)
80mg (oral tablet)
NovartisJul 18, 2001
  • Treatment of hypertension.
  • Use of valsartan to reduce cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EXTRANEAL [IcodextrinC6H9O5(C6H10O5)n(C6H10O5)n(C6H10O5)n]
RX
-
7.5gm/100ml (intraperitoneal solution)
Baxter HlthcareDec 20, 2002
  • Peritoneal dialysis solution.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INSPRA [EplerenoneC24H30O6]
RX
-
25mg (oral tablet)
50mg (oral tablet)
Gd Searle LlcSep 27, 2002
  • Treatment of conditions for which an aldosterone receptor blocker is indicated, such as hypertension, heart failure, and post-myocardial infarction.
  • Treatment of conditions related to hyperaldosteronism such as hypertension and cardiac insufficiency, with eplerenone.
  • Treatment of hypertension.
  • Use of eplerenone in combination with an angiotensin converting enzyme (ace) inhibitor (and optionally a diuretic) for treating congestive heart failure and hypertension.
  • Use of eplerenone in combination with an angiotensin converting enzyme (ace) inhibitor for treating hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KAZANO [Alogliptin BenzoateC18H21N5O2C7H6O2 : Metformin HydrochlorideC4H11N5ClH]
RX
-
eq 12.5mg base : 1gm (oral tablet)
eq 12.5mg base : 500mg (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LEXISCAN [RegadenosonC15H18N8O5H2O]
RX
-
0.4mg/5ml (0.08mg/ml) (intravenous solution)
AstellasApr 10, 2008
  • A method of myocardial perfusion imaging and increasing coronary blood flow.
  • Method for stimulating coronary vasodilation for purposes of imaging the heart.
  • Method for stimulating coronoary vasodilation for purposes of imaging the heart.
  • Method of myocardial imaging.
  • Method of producing coronary vasodilation without peripheral vasodilation.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MICARDIS [TelmisartanC33H30N4O2]
RX
-
20mg (oral tablet)
40mg (oral tablet)
80mg (oral tablet)
Boehringer IngelheimApr 4, 2000
  • Reduction of cardiac tissue damage associated with myocardial infarction.
  • Treatment or prevention of stroke.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NESINA [Alogliptin BenzoateC18H21N5O2C7H6O2]
RX
-
eq 12.5mg base (oral tablet)
eq 25mg base (oral tablet)
eq 6.25mg base (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NIASPAN [NiacinC6H5NO2]
RX
-
1gm (oral tablet, extended release)
500mg (oral tablet, extended release)
750mg (oral tablet, extended release)
AbbvieJul 28, 1997
  • A method of reducing the capacity of extended release nicotinic acid to provoke a flushing reaction by pretreating an individual with a flush inhibiting agent prior to the administration of the extended release nicotinic acid.
  • Method of treating hyperlipidemia with nicotinic acid by dosing once per day in the evening or at night.
  • Reduction in elevated tc and ldl-c by dosing once per day in the evening or at night, with pretreatment with a flush inhibitin agent such as aspirin.
  • Reduction in elevated tc and ldl-c by dosing once per day in the evening or at night.
  • Reduction in risk of recurrent nonfatal myocardial infarction by dosing once per day in the evening or a t night, with pretreatment with a flush inhibitin agent such as aspirin.
  • Reduction in risk of recurrent nonfatal myocardial infarction by dosing once per day in the evening or at night.
  • Reduction in tg by dosing once per day in the evening or at night, with pretreatment with a flush inhibiting agent such as aspirin.
  • Reduction in tg by dosing once per day in the evening or at night.
  • Treatment of primary and mixed dyslipidemia by dosing once per day in the evening or at night, with pretreatment with a flush inhibiting agent such as aspirin.
  • Treatment of primary and mixed dyslipidemia by dosing once per day in the evening or at night.
efficacy
3.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OSENI [Alogliptin BenzoateC18H21N5O2C7H6O2 : Pioglitazone HydrochlorideC19H20N2O3SClH]
RX
-
eq 12.5mg base : eq 15mg base (oral tablet)
eq 12.5mg base : eq 30mg base (oral tablet)
eq 12.5mg base : eq 45mg base (oral tablet)
eq 25mg base : eq 15mg base (oral tablet)
eq 25mg base : eq 30mg base (oral tablet)
eq 25mg base : eq 45mg base (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PRE-OP [HexachloropheneC13H6Cl6O2]
RX
-
480mg (topical sponge)
Davis And GeckApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PRE-OP II [HexachloropheneC13H6Cl6O2]
RX
-
480mg (topical sponge)
Davis And GeckApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

QBRELIS [LisinoprilC21H31N3O52H2O]
RX
-
1mg/ml (oral solution)
Silvergate PharmsJul 29, 2016
  • Acute myocardial infarction.
  • Method of treating hypertension.
  • Method of treatment of heart failure.
  • Reduction of mortality in acute mycardial infarction.
  • Treatment of heart failure.
  • Treatment of hypertension.
  • Treatment of myocardial infarction.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SYMLIN [Pramlintide AcetateC171H267N51O53S2C2H4O2H2O]
RX
-
eq 1.5mg base/1.5ml (eq 1mg base/ml) (subcutaneous injectable)
eq 2.7mg base/2.7ml (eq 1mg base/ml) (subcutaneous injectable)
Astrazeneca AbSep 25, 2007
  • Treatment of diabetes with an amylin agonist, including with insulin.
  • Treatment of diabetes with an amylin agonist.
  • Use of an amylin agonist to reduce gastric motility and treat post prandial hypergylcemia.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VALIUM [DiazepamC16H13ClN2O]
RX
-
10mg (oral tablet)
2mg (oral tablet)
5mg (oral tablet)
RocheApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Dial

SORE THROAT [pharyngitis]
   Garlic (Allium sativum L.) kills bacteria and some viruses. Place half a clove of garlic between the teeth and each cheek and/or suck on clove. Alternately, buy garlic lozenges and use as directed. Garlic has antiviral, anti-fungal and antibacterial properties.
Mechanism - allyl 2-propenethiosulfinate or diallyl thiosulfinate
GuydeMaupassant | August 7th, 2020
efficacy
4.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

COLDS COUGH FEVER [acute viral rhinopharyngitis - acute cor]
   ...rink 1 time per day.

This may just be what we need to help prevent COVID-19 infections!

Sulfur Compounds: aliin, allicin, ajoene, allylpropl, diallyl, trisulfide, sallylcysteine, vinyldithiines, S-allylmercaptocystein, and others.

Amino acids: arginine and others.

Enzymes: allinase, pe......ines, S-allylmercaptocystein, and others.

Amino acids: arginine and others.

Enzymes: allinase, peroxidases, myrosinase, and others.

Allicin (diallyl thiousulfinate or diallyl disulfide) does not exist in garlic until it is crushed or cut. Crushing the garlic bulb activates the enzyme allin...NathanielHawthorne | August 13th, 2020
efficacy
5.0  (1)
side effects
1.0  (1)
danger
1.0  (1)

UNK


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Dial

ABSINTHIUM (Artemisia absinthium)ARAB3
   The flowering tops and leaves of Artemisia Absinthium, Linné (Nat. Ord. Compositae); Europe, Siberia, Barbary, Newfoundland, and the United... / ... in the integument of the hypogastrium. The French liquer Absinthe, which is a viscous alcoholic cordial, and Wermuth, a German beer, both depend upon wormwood for their activity. Therapy.—External. ... / ...used for the expulsion of the intestinal parasites-Ascaris vermicularis and Ascaris lumbricoides. The oil may be given in doses of 1 to 5 drops. 3

APOCYNUM CANNABINUM
   The root of Apocynum cannabinum, Linné (Nat. Ord. Apocynaceae) gathered in autumn after the leaves and fruit have matured. Grows throughout the... / .... On the other hand, the feeble pulse, soft and of little force, indicates its selection as the remedial agent. The atonic state which readily permits of exudation from the blood vessels is the ideal ... / ...may be looked for. Under these circumstances we have removed enormous dropsical swellings with it, giving quick relief from dyspnea and3

ARNICA MONTANA
   The dried flower-heads of Arnica montana, Linné (Nat. Ord. Compositae). A perennial of Siberia and the cooler parts of Europe; also found in... / ...tion; lack of control over urine and feces; sleeplessness from impeded respiration; and dull praecordial pain from ‘heart strain’; muscular pain and soreness when the limbs are moved; tensive backac...3

AURANTII DULCIS CORTEX
   The outer rind of the ripe, fresh fruit of Citrus Aurantium. sinensis, Gallesio (Nat. Ord. Rutaceae) Common Names: Sweet Orange Peel (of Sweet... / ... to be given during fevers and the exanthemata where acids are craved. It is par excellence the remedial agent in scurvy of infants, as well as adults, and if given early will abort this unpleasant di...3

CACTUS (Selenicereus spp.)
   ... action, whether feeble, irregular, or tumultuous; cardiac disorders with mental depression, praecordial oppression, and apprehension of danger and death; nervous disorders with feeble heart action; t......sion, often amounting to hypochondria and fear of impending death. Associated with these are praecordial weight and oppression and difficult breathing. The control over the nervous system is somewhat ...3

CAULOPHYLLUM
   The rhizome and roots of Caulophyllum thalictroides (Linné, Michaux (Nat. Ord. Berberidaceae). In rich woods in the eastern half of the United... / ... with greater safety than forceps. As an ingredient of the Compound Syrup of Mitchella (Mother's Cordial), it is still relied upon by some physicians as a good partus praeparator. Caulophyllum is a go... / ...of strength and rapid involution of the womb following labor. The dose of the syrup is from 2 fluidrachms to 1/2 fluidounce, 2 or 3 times a day.3

CONVALLARIACONVA
   The rhizome and rootlets of Convallaria majalis, Linné (Nat. Ord. Liliaceae.) Common Name: Lily of the Valley. Principal Constituents.—Two... / ...ndly is an ideal heart stimulant, and such is convallaria. Convallaria relieves the sense of praecordial oppression and faintness that so frequently follows prostrating diseases. Not alone is it a hea... / ...carditis and endocarditis, using it in fractional doses. Convallaria is of less service in stenosis of the aorta than in mitral disorders.3

CRATAEGUSCRAN6
   The ripe fruit and bark of (1) Crataegus Oxyacantha, Linné, and (2) other species of Crataegus. (Nat. Ord. Rosaceae) 1. England and other parts... / ...depression or neurasthenia; mitral regurgitation, with valvular insufficiency; cardiac pain; praecordial oppression; dyspnea; rapid and feeble heart action; marked anemia, associated with heart irreg... / ...trial; and as yet with no rational explanation of its reputed powers. The smaller doses are suggested as more likely to succeed than full doses.3

EUPATORIUM PERFOLIATUM
   The flowering tops and leaves of Eupatorium perfoliatum, Linné (Nat. Ord. Compositae). Swamps and low meadows throughout the United States. Dose,... / ... a rule, followed by perspiration; there is deepseated, aching pain, as if “in the bones”, praecordial oppression, and great thirst. If, however, the fever lasts all day, slight sweating may occur a... / ...tonic and stomachic, when given in small doses it improves the appetite and digestion and thus favors a more rapid and perfect convalescence.3

LEPTANDRA (Veronicastrum virginicum)VEVI4
   The rhizome and rootlets of Veronicastrum virginicum (L.) Farw., (Leptandra virginica, Nuttall), (Nat. Ord. Scrophulariaceae). A tall perennial plant indigenous to the eastern half... / ... 20 drops every hour until the diarrhea ceases. Glyconda may be substituted for the neutralizing cordial, if sugar is contraindicated.3

LOBELIALOBEL
   The leaves, tops, and seeds of Lobelia inflata, Linné (Nat. Ord. Lobeliaceae). Abundant in the United States. Dose, 1 to 60 grains. Common... / ...current moving with difficulty; short, labored breathing; sense of suffocation; dyspnea with praecordial oppression; pain in chest of a heavy, sore, or oppressive character; pulmonary apoplexy (full d...3

LYCOPUSLYSH2
   The whole herb Lycopus virginicus, Linné (Nat. Ord. Labiatae). Common in shady, moist and boggy places throughout the United States. Dose, 1 to... / ...of heart disease characterized by irritability, irregularity, and weakness, with dyspnea and praecordial oppression. Lycopus powerfully increases the contraction of the non-striated muscular fibers, p... / ...in simple diarrhea (lientery), dysenteric diarrhea, and especially in the diarrhea of phthisis, and the gastric disturbances of the drunkard.3

MATRICARIA
   The dried flower-heads of Matricaria Chamomilla, Linné (Nat. Ord. Compositae). Wastes of Europe, Asia, and Australia. Dose, 1 to 60... / ..., fail to show decided so-called physiological action. Matricaria, simple and safe as it is, is remedially potent. Could it more generally have taken the place of “soothing syrups”, so largely destr... / ...to the actual pain suffered. This remedy should be resorted to when one is tempted to employ opiates and other more powerful pain relievers.3

MENTHA PIPERITA
   The leaves and tops of Mentha piperita, Smith (Mentha X piperita L.) (Nat. Ord. Labiatae). Europe and the United States. Dose, 60 to 120... / ...llay nausea and vomiting, and to break up a cold. It forms a part of the well-known Neutralizing Cordial. The essence is a common and unexcelled carminative for gastrodynia and the flatulent colic of ... / ...and gives relief in the cough of acute bronchitis and pneumonia.3

MITCHELLAMITCH
   The whole plant of Mitchella repens, Linné (Nat. Ord. Rubiaceae). Dry... / ...ose, 5 to 60 drops. 2. Syrupus Mitchellae Compositus, Compound Syrup of Partridgeberry (Mothers' Cordial). (Contains Mitchella, Helonias, Viburnum Opulus and Caulophyllum, Brandy, Sugar and Essence of...... previously occurred. As a female regulator it has also had many devoted advocates. The Mother's Cordial is a popular and more rational preparation.3


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Physician's Materia Medica on Dial

COLCHICUMCOLCH
   The corm, also the seed of COLCHICUM AUTUMNALE. Lin. Pur gative, diuretic, diaphoretic, nauseant. Prescribed especially in gout, in which disease it is our most important remedial agent. Dose of the seed or root in substance, 0.13 to 0.5 Grm. (2 to 8 grs.).4

HAEMO-MANGAN
   A ferruginous tonic, each fluidrachm containing; Iron Citro peptonate, 1% grs.; ManganeseCitropeptonate, 1/4 gr. The preparation resembles dialysed iron in its freedom from astringency and acidity, but it has the advantage over that preparation in the fact that the iron is presented in the form of an organic compound which is readily assimilable. Clinical experience declares it a most eflicient agent in all conditions in which a blood-euriching tonic is indicated. Dose, 4 c. c. (1 fluidrachm) a4

NEUTRALIZING CORDIAL (Compound Syrup of Rhubarb and Potassa. N. F.)
   Stomachic, laxative, antacid. A favorite remedy with many for certain dyspeptlc conditions, in which constipation and acidity of the stomach are prominent symptoms. Each fluidrachm repre sents; Rhubarb, 2 1/4 grs.; Cinnamon 1 1/8 grs.; Golden-seal, 1 1/8 grs.; Potassium Bicarb., 2 1/4 grs-; Oil Peppermint, 3-50 M Dose, 4 to 8 c. c. (1 to 2 fluidrachms) when distress is felt after eating. It is best taken as much as two hours after a meal.4


References

1) Bergner, Pal., Griswold, Alexandra F., Hufford, David J., et al. . Morton Grove, Il: Publications International, 2017.
2) Motteshard, Tammy D. "The Benefits Of The Use Of Garlic In Herbal Preparations: Chemical Constituents", www.herballegacy.com/Motteshard_Chemical.html.
3) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.
4) Nelson, Baker & Co., 1904, Physician's Handy Book of Materia Medica and Therapeustics, Detroit, Michigan.